Financial Statements · Financial Reporting
AS Synerall
Official identifier 14036817Record date 31 Dec 2021
Report
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2021
- Period start
- 1 Jan 2021
- Submitted date
- 28 Mar 2022
Report
- Consolidated
- Yes
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Profit distribution proposal | Retained earnings (loss) from previous periods | -2,613,149 |
| Kasumi jaotamise otsus | Retained earnings (loss) from previous periods | -2,613,149 |
| Unconsolidated bilanss | Assets | 3,503,957 |
| Unconsolidated bilanss | Cash and cash equivalents | 62,463 |
| Unconsolidated bilanss | Current assets | 437,358 |
| Unconsolidated bilanss | Current liabilities | 348,993 |
| Unconsolidated bilanss | Equity | 3,154,964 |
| Unconsolidated bilanss | Share capital at nominal value | 5,040,000 |
| Unconsolidated bilanss | Non-current assets | 3,066,599 |
| Unconsolidated bilanss | Retained earnings (loss) from previous periods | -2,274,799 |
| Unconsolidated income statement (scheme 1) | Depreciation and impairment of non-current assets | -198,014 |
| Unconsolidated income statement (scheme 1) | Labour costs | -653,786 |
| Unconsolidated income statement (scheme 1) | Revenue | 1,930,230 |
| Unconsolidated income statement (scheme 1) | Annual period profit / loss | 390,771 |
| Unconsolidated income statement (scheme 1) | Operating profit (loss) | 390,764 |
| Unconsolidated income statement (scheme 1) | Profit (loss) before income tax | 390,771 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 198,014 |
| Unconsolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 390,764 |
| Consolidated bilanss | Assets | 3,650,300 |
| Consolidated bilanss | Cash and cash equivalents | 122,965 |
| Consolidated bilanss | Current assets | 781,120 |
| Consolidated bilanss | Current liabilities | 636,422 |
| Consolidated bilanss | Equity | 3,013,878 |
| Consolidated bilanss | Share capital at nominal value | 5,040,000 |
| Consolidated bilanss | Non-current assets | 2,869,180 |
| Consolidated bilanss | Retained earnings (loss) from previous periods | -2,613,149 |
| Consolidated income statement scheme 1 | Depreciation and impairment of non-current assets | -198,115 |
| Consolidated income statement scheme 1 | Labour costs | -984,264 |
| Consolidated income statement scheme 1 | Revenue | 2,615,656 |
| Consolidated income statement scheme 1 | Annual period profit / loss | 588,035 |
| Consolidated income statement scheme 1 | Profit (loss) before income tax | 602,474 |
| Consolidated income statement scheme 1 | Operating profit (loss) | 602,467 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Depreciation and impairment of non-current assets | 198,115 |
| Consolidated rahavoogude aruanne kaudsel meetodil | Operating profit (loss) | 602,467 |
| Note: Labour costs | Employees | 19 |
| Note: Labour costs | Labour costs | 984,264 |
| Employees | 15 |
Linked company
Company: AS Synerall